Novo Nordisk A/S (NVO) Options Chain & Prices $46.59 -0.92 (-1.93%) As of 03:57 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest NVO Put and Call Options List 12/15/2028 6/16/2028 1/21/2028 12/17/2027 9/17/2027 6/17/2027 3/19/2027 1/15/2027 12/18/2026 11/20/2026 10/23/2026 10/16/2026 10/9/2026 10/2/2026 9/25/2026 9/18/2026 9/11/2026 9/4/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades9/4/2026$38.00$9.521Call1 - - 7(+2)157.28% (+47.43%)0.99685619/4/2026$41.00$6.526Call1 - - 8(+2)115.17% (+35.14%)0.99285819/4/2026$41.50$6.027Call4 - - 2(+1)107.83% (+33.11%)0.991849/4/2026$42.00$5.527Call4 - 117(+3)100.38% (+31.07%)0.99056249/4/2026$42.50$5.028Call2 - - 4(+2)92.82% (+29.02%)0.98909829/4/2026$43.00$0.009Put713322(+2)85.14% (+26.96%)-0.01274279/4/2026$43.00$4.530Call2 - - 20(+2)85.14% (+26.96%)0.98735229/4/2026$43.50$0.010Put4 - 3506(+0)77.32% (+24.82%)-0.01486129/4/2026$43.50$4.030Call2 - - 6(+2)77.31% (+24.82%)0.98523229/4/2026$44.00$0.011Put4 - 1377(-74)69.35% (+22.36%)-0.0174924 Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 9/4/2026$44.00$3.531Call451826147(-45)69.34% (+22.36%)0.982601119/4/2026$44.50$0.012Put139 - 104684(-67)61.21% (+19.00%)-0.020848359/4/2026$44.50$3.032Call101817(-4)61.20% (+18.99%)0.97924539/4/2026$45.00$0.012Put13921421004(-164)52.91% (+14.02%)-0.025391399/4/2026$45.00$2.533Call281212402(-55)52.91% (+14.01%)0.9747129/4/2026$45.50$0.014Put78718420(-163)44.80% (+7.65%)-0.033046189/4/2026$45.50$2.036Call43102431(-55)44.80% (+7.65%)0.967048139/4/2026$46.00$0.022Put1894750940(+90)38.45% (+2.02%)-0.054533439/4/2026$46.00$1.543Call271122541424(-83)38.44% (+2.02%)0.945533749/4/2026$46.50$0.054Put274136811523(+1003)35.53% (-0.61%)-0.123179639/4/2026$46.50$1.076Call17245621018(-959)35.53% (-0.61%)0.876832389/4/2026$47.00$0.148Put34337141869(-6)34.94% (+0.65%)-0.273291829/4/2026$47.00$0.670Call1,0382714801388(+132)34.94% (-1.12%)0.7268082089/4/2026$47.50$0.343Put593016111(-16)33.94% (-2.38%)-0.488173179/4/2026$47.50$0.365Call7701984602053(+899)35.28% (-1.04%)0.5139621269/4/2026$48.00$0.654Put571343264(+1)36.12% (-1.20%)-0.702561139/4/2026$48.00$0.174Call2,7391,4136162184(+107)36.12% (-1.20%)0.3052162169/4/2026$48.50$1.061Put821157(+1)37.64% (-1.61%)-0.8576949/4/2026$48.50$0.076Call11932621467(+515)38.55% (-0.70%)0.157351229/4/2026$49.00$0.035Call1083413844(+15)40.30% (-1.74%)0.078322299/4/2026$49.50$0.020Call441330436(+0)44.67% (-0.82%)0.04421999/4/2026$50.00$2.511Put33 - - 22(+0)50.62% (+1.27%)-0.98065919/4/2026$50.00$0.014Call431973192(-55)50.61% (+1.27%)0.030409209/4/2026$51.00$0.011Call1 - - 811(-4)64.26% (+6.91%)0.02015419/4/2026$52.00$0.010Call94 - 1393(+24)77.68% (+12.54%)0.01535159/4/2026$55.00$7.507Put1 - - 0(+0)113.25% (+26.96%)-0.99542319/4/2026$55.00$0.007Call1 - - 1360(-5)113.25% (+26.96%)0.0081921End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Johnson & Johnson Options Merck & Co., Inc. Options Novartis Options Pfizer Options Bristol Myers Squibb Options Sanofi Options GSK Options Takeda Pharmaceutical Options Teva Pharmaceutical Industries Options Royalty Pharma Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:NVO) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredCongress Just Opened the FloodgatesThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredAmerican retirees will miss THIS. Big Banks just moved in.Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...Cedar Gold Group | SponsoredFDA Momentum is Building Around NNVC!NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies ...Smallcaps Daily | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
